ABC disease affects millions world-wide. The World Health Organization (WHO) reports that the incidence of this common but dangerous disease has increased over 60% since 2000.

This research study is testing the effectiveness of an investigational medication at reducing the symptoms of ABC.

Qualified participants in this study must be:

  • at least 18 years of age
  • diagnosed with ABC for at least 6-months
  • Qualified participants will be seen by a doctor and receive all study related care, tests and medications at no cost. Compensation for time and travel may be available.